Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19

Phase 3

Recruiting

• Conditions: COVID-19.; Covid-19; U07.1

• Registration Number: IRCT20080901001165N48
• Lead Sponsor: iak pharmaceutical company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

age equal or more than 18 years;
The patient have written consciously and freely consent to participate in the study.
Confirmed diagnosis of COVID-19, with Laboratory (RT-PCR) confirmation.
Confirmed diagnosis of COVID-19, with lung CT-Scan result, which is typical for COVID-19 pulmonary involvement.
The patient has clinical symptom of COVID-19 (dry cough, respiratory distress, fever)
Less than 7 days have passed since the onset of symptoms;

Exclusion Criteria

The patient is in another clinical trial at the same time.
The patient needs to receive medical care from the intensive care unit

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical symptoms (dry cough). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: Physical examination,questionnaire.;Clinical symptoms (respiratory distress). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: pulse oxymetery device.;Clinical symptoms (fever). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: Thermometer.

Secondary Outcome Measures

Name	Time	Method
ab tests changes. Timepoint: daily monitoring, but the before the intervention initiation (baseline) and day 7 results will recorded on designed checklist. Method of measurement: blood sample, laboratory analysis.